Searchable abstracts of presentations at key conferences in endocrinology
Previous issue | Volume 63 | ECE2019 | Next issue

21st European Congress of Endocrinology

Lyon, France
18 May 2019 - 21 May 2019

Card image cap
18-21 May 2019, Lyon, France

Symposia

Craniopharyngioma; a challenging tumour to treat and a difficult aftermath

ea0063s12.2 | Craniopharyngioma; a challenging tumour to treat and a difficult aftermath | ECE2019

New potential treatment alternatives in patients with papillary craniopharyngioma

Juratli Tareq

Craniopharyngiomas are surgically challenging brain tumors. Postoperatively, quality of life is often significantly impaired due to neurological and endocrinological complications. Currently, FDA approved systemic treatments are not available for patients in whom craniopharyngiomas recur after surgery and radiation. Papillary craniopharyngiomas are characterized by the presence of BRAFV600E mutations. In this presentation, the authors generate an o...

ea0063s12.3 | Craniopharyngioma; a challenging tumour to treat and a difficult aftermath | ECE2019

How to manage the long-term consequences of hypothalamic damages

Erfurth Eva Marie

When a craniopharyngioma (CP) causes hypothalamus (HT) damage this will result in hypothalamic obesity (HO), cognitive dysfunction and increased stroke mortality. Suggested treatment when the HT is affected by a CP is subtotal resection and in some cases followed by cranial radiotherapy (CRT). In the preoperative phase, a multidisciplinary team may suggest HT sparing surgery with subtotal tumour removal. If in spite of all efforts the HT is damaged, there will be an immediate ...